Asacol Leadership

Asacol Delivers Leadership Through a Wealth of Evidence and Experience

Asacol Delivers Leadership Through a Wealth of Evidence and Experience

Confidence in your therapy choice is important when choosing an Ulcerative Colitis medication.

Evidence | Experience

* July 1, 2007-June 30, 2008.

† This information is an estimate derived from the use of information under license from the following IMS National Prescription Data for the12-month period ending January 2008. IMS expressly reserves all rights, including rights of copying, distribution, and republication.

‡ IMS National Prescription Data from 1992-July 2006.

§ American Gastroenterological Association.

|| Crohn's & Colitis Foundation of America.

¶ Verispan Managed Care Formulary Drug Audit, spring 2008. The spring 2008 data represent an estimated 63%of all US HMO subscribers whose prescription benefits are controlled by formularies.

References: 1. Data on file, Procter & Gamble Pharmaceuticals, Inc.
Asacol (mesalamine) delayed-release tablets, available only by prescription, are indicated to treat mild to moderate flare-ups of ulcerative colitis and maintain remission of ulcerative colitis. Asacol is generally well-tolerated. In studies of flare-ups, some people taking Asacol reported headache, abdominal pain, general pain, rash, upset stomach, and worsening of colitis symptoms. In a six-month maintenance study, some people reported headache, runny nose, general pain, sore throat, infection, and nervousness. You should not take Asacol if you are allergic to Asacol or to salicylates such as aspirin. Tell your doctor if you have kidney problems or a history of kidney disease. It is recommended that all people have their kidney function tested prior to starting Asacol tablets and periodically while on Asacol therapy. Serious side effects may occur. If you have questions about taking Asacol, please talk to your doctor.
Adjust Font SizeSmall TextMedium TextLarge Text

This information was printed from Asacol.com.
Visit Asacol.com to get more information on Ulcerative Colitis.
Asacol is a registered trademark of Medeva Pharma Suisse AG, used under license by Procter & Gamble Pharmaceuticals, Inc.

Privacy BBB OnLine